Jyong Biotech Ltd. Ordinary Shares (MENS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $2.06 (-0.96%), Market cap $0.15B, 52-week low–high $1.46 ~ $65.62.
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Financial statements, price targets, institutional (13F) holdings and related news for Jyong Biotech Ltd. Ordinary Shares are updated in real time on BlackAll Trade.
Jyong Biotech Ltd. Ordinary Shares trades at $2.06 (-0.96%). Real-time quotes and charts are available on BlackAll Trade.
Jyong Biotech Ltd. Ordinary Shares has a market cap of about $0.15B.
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and A